Role of cytokines in cardiovascular diseases: A focus on endothelial responses to inflammation

Clinical Science

Volumn 108, Issue 3, 2005, Pages 205-213

  Kofler, Sieglinde ^a   Nickel, Thomas ^a   Weis, Michael ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Cardiovascular disease; Cytokine; Endothelial response; Inflammation

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA CHEMOKINE; CD40 ANTIGEN; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPIDERMAL GROWTH FACTOR; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 3; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOTOXIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR; RANTES; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; CARDIOVASCULAR DISEASE; ENDOTHELIUM; GENETIC POLYMORPHISM; HUMAN; INFLAMMATION; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REVIEW; VASOMOTOR REFLEX;

CARDIOVASCULAR DISEASES; CYTOKINES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION;

EID: 14844303281     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20040174     Document Type: Review

References (93)

1. Kishimoto, T., Taga, T. and Akira, S. (1994) Cytokine signal transduction. Cell 76, 253-262
2. Mackay, C. R. (2001) Chemokines: immunology's high impact factors. Nat. Immunol. 2, 95-101
3. Hanada, T. and Yoshimura, A. (2002) Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev. 13, 413-421
4. Taniguchi, T. (1995) Cytokine signaling through nonreceptor protein tyrosine kinases. Science 268, 251-255
5. O'Shea, J. J., Gadina, M. and Schreiber, R. D. (2002) Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell 109 (Suppl.), S121-S131
6. Attisano, L. and Wrana, J. L. (2002) Signal transduction by the TGF-β superfamily. Science 296, 1646-1647
7. Mombouli, J. V. and Vanhoutte, P. M. (1999) Endothelial dysfunction: from physiology to therapy. J. Mol. Cell. Cardiol. 31, 61-74
8. Mantovani, A., Bussolino, F. and Dejana, E. (1992) Cytokine regulation of endothelial cell function. FASEB J. 6, 2591-2599
9. Pober, J. S. (1999) Immunobiology of human vascular endothelium. Immunol. Res. 19, 225-232
10. Krishnaswamy, G., Kelley, J., Lakshiminarayan, Y., Smith, J. K. and Chi, D. S. (1999) Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. J. Interferon Cytokine Res. 19, 91-104
11. Neumann, F. J., Ott, I., Gawaz, M. et al. (1995) Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 92, 748-755
12. Weis, M., Wildhirt, S. M., Schulze, C. et al. (1999) Modulation of coronary vasomotor tone by cytokines in cardiac transplant recipients. Transplantation 68, 1263-1267
13. Deliargyris, E. N., Raymond, R. J., Theoharides, T. C., Boucher, W. S., Tate, D. A. and Dehmer, G. J. (2000) Sites of interleukin-6 release in patients with acute coronary syndromes and in patients with congestive heart failure. Am. J. Cardiol. 86, 913-918
14. Hansson, G. K., Libby, P., Schonbeck, U. and Yan, Z. Q. (2002) Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ. Res. 91, 281-291
15. Tousoulis, D., Davies, G., Stefanadis, C., Toutouzas, P. and Ambrose, J. (2003) Inflammatory and thrombotic mechanisms in coronary atherosclerosis. Heart 89, 993-997
16. Mach, F., Schönbeck, U., Bonnefoy, J., Pober, J. S. and Libby, P. (1997) Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40. Circulation 96, 396-399
17. Aoki, N., Siegfried, M. and Lefer, A. M. (1989) Anti-EDRF effect of tumor necrosis factor in isolated, perfused cat carotid arteries. Am. J. Physiol. 256, H1509-H1512
18. Iversen, P. O., Nicolaysen, A., Kvernebo, K., Benestad, H. B. and Nicolaysen, G. (1999) Human cytokines modulate arterial vascular tone via endothelial receptors. Eur. J. Physiol. 439, 93-100
19. Katz, S. D., Rao, R., Berman, J. W. et al. (1994) Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure. Relation to nitric oxide-dependent vasodilation in the forearm circulation. Circulation 90, 12-16
20. Vanderheyden, M., Kersschot, E. and Paulus, W. J. (1998) Pro-inflammatory cytokines and endothelium-dependent vasodilation in the forearm. Serial assessment in patients with congestive heart failure. Eur. Heart J. 19, 747-752
21. Bhagat, K. and Vallance, P. (1997) Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo. Circulation 96, 3042-3047
22. Locksley, R. M., Killeen, N. and Lenardo, M. J. (2001) The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104, 487-501
23. Madge, L. A. and Pober, J. S. (2001) TNF signaling in vascular endothelial cells. Exp. Mol. Pathol. 70, 317-325
24. Collins, T., Read, M. A., Neish, A. S., Whitley, M. Z., Thanos, D. and Maniatis, T. (1995) Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers. FASEB J. 9, 899-909
25. Kupatt, C., Habazettl, H., Goedecke, A. et al. (1999) Tumor necrosis factor-α contributes to ischemia- and reperfusion-induced endothelial activation in isolated hearts. Circ. Res. 84, 392-400
26. 2 and TNF-α and its effects on ICAM-1 expression in endothelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 279, L302-L311
27. Sullivan, G. W., Sarembock, I. J. and Linden, J. (2000) The role of inflammation in vascular diseases. J. Leukocyte Biol. 67, 591-602
28. Weis, M., Schlichting, C. L., Engleman, E. G. and Cooke, J. P. (2002) Endothelial determinants of dendritic cell adhesion and migration: new implications for vascular diseases. Arterioscler., Thromb., Vasc. Biol. 22, 1817-1823
29. Yoshizumi, M., Perrella, M. A., Burnett, J. C. and Lee, M. E. (1993) Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ. Res. 73, 205-209
30. Ito, A., Tsao, P. S., Adimoolam, S., Kimoto, M., Ogawa, T. and Cooke, J. P. (1999) Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation 99, 3092-3095
31. Niebauer, J., Dulak, J., Chan, J. R., Tsao, P. S. and Cooke, J. P. (1999) Gene transfer of nitric oxide synthase: effects on endothelial biology. J. Am. Coll. Cardiol. 34, 1201-1207
32. Napoli, C., Quehenberger, O., De Nigris, F., Abete, P., Glass, C. K. and Palinski, W. (2000) Mildly oxidized low density lipoprotein activates multiple apoptotic signaling pathways in human coronary cells. FASEB J. 14, 1996-2007
33. Ross, R. (1999) Atherosclerosis: an inflammatory disease. N. Engl. J. Med. 340, 115-126
34. Ridker, P. M. (2001) Role of inflammatory biomarkers in prediction of coronary heart disease. Lancet 358, 946-948
35. Ridker, P. M., Rifai, N., Pfeffer, M., Sacks, F., Lepage, S. and Braunwald, E. (2000) Elevation of tumor necrosis factor-α and increased risk of recurrent coronary events after myocardial infarction. Circulation 101, 2149-2153
36. Lindmark, E., Diderholm, E., Wallentin, L. and Siegbahn, A. (2001) Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy. JAMA, J. Am. Med. Assoc. 286, 2107-2113
37. Mulvihil, N. and Foley, J. B. (2002) Inflammation in acute coronary syndromes. Heart 87, 201-204
38. Rus, H. G., Vlaicu, R. and Niculescu, F. (1996) Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall. Atherosclerosis 127, 263-271
39. Tellides, G., Tereb, D. A., Kirkiles-Smith, N. C. et al. (2000) Interferon-gamma elicits arteriosclerosis in the absence of leukocytes. Nature (London) 403, 207-211
40. Celletti, F., Waugh, J., Amabile, P., Brendolan, A., Hilfiker, P. R. and Dake, M. D. (2001) Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat. Med. 7, 425-429
41. Heeschen, C., Dimmeler, S., Fichtlscherer, S. et al. (2004) Prognostic value of placental growth factor in patients with acute chest pain. JAMA, J. Am. Med. Assoc. 291, 435-441
42. Blankenberg, S., Tiret, L., Bickel, C. et al. (2002) Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 106, 24-30
43. Heeschen, C., Dimmeler, S., Hamm, C. W. et al. (2003) Soluble CD40 ligand in acute coronary syndromes. N. Engl. J. Med. 348, 1104-1111
44. Csiszar, A., Ungvari, Z., Koller, A., Edwards, J. G. and Kaley, G. (2003) Aging-induced proinflammatory shift in cytokine expression profile in rat coronary arteries. FASEB J. 17, 1183-1185
45. Tedgui, A. and Mallat, Z. (2001) Anti-inflammatory mechanisms in the vascular wall. Circ. Res. 88, 877-887
46. Heeschen, C., Dimmeler, S., Hamm, C. W. et al. (2003) Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 107, 2109-2114
47. Smith, C., Yndestad, A., Halvorsen, B. et al. (2004) Potential anti-inflammatory role of activin A in acute coronary syndromes. J. Am. Coll. Cardiol. 44, 369-375
48. Kelly, R. A. and Smith, T. W. (1997) Cytokines and cardiac contractile function. Circulation 95, 778-781
49. Levine, B., Kalman, J., Mayer, L., Fillit, H. M. and Packer, M. (1990) Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N. Engl. J. Med. 323, 236-241
50. Torre-Amione, G., Kapadia, S., Benedict, C., Oral, H., Young, J. B. and Mann, D. L. (1996) Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J. Am. Coll. Cardiol. 27, 1201-1206
51. Rauchhaus, M., Doehner, W., Francis, D. P. et al. (2000) Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 102, 3060-3067
52. Dibbs, Z., Thornby, J., White, B. G. and Mann, D. L. (1999) Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: implications for clinical trials. J. Am. Coll. Cardiol. 33, 1935-1942
53. Moller, D. and Kaufman, K. (2004) Metabolic syndrome: a clinical and molecular perspective. Annu. Rev. Med., DOI:10.1146/annurev.med.56.082103.104751
54. Trayhurn, P. and Wood, I. S. (2004) Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br. J. Nutr. 92, 347-355
55. Flowe, L., Gray, R., J., P. and Mohammed-Ali, V. (2003) Stimulation of interleukin-6 release by interleukin-1β from human adipocytes. Cytokine 21, 32-37
56. Cooke, J. P. and Oka, R. K. (2002) Does leptin cause vascular disease. Circulation 106, 1904-1905
57. Auer, J., Weber, T., Berent, R., Lassnig, E., Lamm, G. and Eber, B. (2003) Genetic polymorphisms in cytokine and adhesion molecule genes in coronary artery disease. Am. J. Pharmacogenomics 3, 317-328
58. Van Doornum, S., McColl, G. and Wicks, I. (2002) Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum. 46, 862-873
59. Sattar, N., McCarey, D. W., Capell, H. and McInnes, I. B. (2003) Explaining how 'high-grade' systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 108, 2957-2963
60. Suissa, M., Bernatsky, S., Hudson, M. and Kezouh, A. (2004) DMARD use and the risk of acute myocardial infarction in rheumatoid arthritis. Annual European Congress of Rhuematology, OP0038
61. Moder, J., Miller, T. and Tazelaar, H. (1999) Cardiac involvement in systemic lupus erythematosus. Mayo Clin. Proc. 74, 275-284
62. Asanuma, Y., Oeser, A., Shintani, A. et al. (2003) Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N. Engl. J. Med. 349, 2407-2415
63. Abusamieh, M. and Ash, J. (2004) Atherosclerosis and systemic lupus erythematosus. Cardiol. Rev. 12, 267-275
64. Jackson, J. R., Seed, M. P., Kircher, C. H., Willoughby, D. A. and Winkler, J. D. (1997) The codependence of angiogenesis and chronic inflammation. FASEB J. 11, 457-465
65. Carmeliet, P. (2000) Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6 389-395
66. Griffioen, A. W. and Molema, G. (2000) Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases and chronic inflammation. Pharmacol. Rev. 52, 237-268
67. Naldini, A., Pucci, A., Bernini, C. and Carraro, F. (2003) Regulation of angiogenesis by Th1- and Th2-type cytokines. Curr. Pharm. Des. 9, 511-519
68. Neufeld, G., Cohen, T., Gengrinovitch, S. and Poltorak, Z. (1999) Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13, 9-22
69. Bergers, G., Javaherian, K., Lo, K. M., Folkman, J. and Hanahan, D. (1999) Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 284, 808-812
70. Gullestad, L., Aukrust, P., Ueland, T. et al. (1999) Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure. J. Am. Coll. Cardiol. 34, 2061-2067
71. Gullestad, L., Ueland, T., Brunsvig, A. et al. (2001) Effect of metoprolol on cytokine levels in chronic heart failure: a substudy in the Metoprolol Controlled-Release Randomised Intervention Trial in Heart Failure (MERIT-HP). Am. Heart J. 141, 418-421
72. Ikonomidis, I., Andreotti, E, Economou, E., Stefanadis, C., Toutouzas, P. and Nihoyannopoulos, P. (1999) Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation 100, 793-798
73. Vaughan, C. J. and Gotto, Jr, A. M. (2004) Update on statins: 2003. Circulation 110, 886-892
74. Weis, M., Pehlivanli, S., Meiser, B. M. and von Scheidt, W. (2001) Simvastatin treatment is associated with improvement in coronary endothelial function and decreased cytokine activation in patients after heart transplantation. J. Am. Coll. Cardiol. 38, 814-818
75. Rezaie-Majd, A., Maca, T., Bucek, R. A. et al. (2002) Simvastatin reduces expression of cytokines interleukin-6, interleukin-8 and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients. Arterioscler., Thromb., Vasc. Biol. 22, 1194-1199
76. Schieffer, B., Bunte, C., Witte, J. et al. (2004) Comparative effects of AT1-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease. J. Am. Coll. Cardiol. 44, 362-368
77. Kharbanda, R. K., Walton, B., Allen, M. et al. (2002) Prevention of inflammation-induced endothelial dysfunction: a novel vasculo-protective action of aspirin. Circulation 105, 2600-2604
78. Monakier, D., Mates, M., Klutstein, M. W. et al. (2004) Rofecoxib, a COX-2 inhibitor, lowers C-reactive protein and interleukin-6 levels in patients with acute coronary syndromes. Chest 125, 1610-1615
79. Zeuke, S., Ulmer, A., Kusumoto, S., Katus, H. and Heine, H. (2002) TLR4-mediated inflammatory activation of human coronary artery endothelial cells by LPS. Cardiovasc. Res. 56, 126-134
80. Kinlay, S., Schwartz, G. G., Olsson, A. G. et al. (2003) High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study. Circulation 108, 1560-1566
81. Kleemann, R., Verschueren, L., de Rooij, B. et al. (2004) Evidence for anti-inflammatory activity of statins and PPAR activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes in vitro. Blood 103, 4188-4194
82. De Caterina, R., Libby, P., Peng, H. B. et al. (1995) Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest. 96, 60-68
83. Fichtlscherer, S., Rossig, L., Breuer, S., Vasa, M., Dimmeler, S. and Zeiher, A. M. (2001) Tumor necrosis factor antagonism with etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure. Circulation 104, 3023-3025
84. Branen, L., Hovgaard, L., Nitulescu, M., Bengtsson, E., Nilsson, J. and Jovinge, S. (2004) Inhibition of tumor necrosis factor-α reduces atherosclerosis in apolipoprotein E knockout Mice. Arterioscler., Thromb., Vasc. Biol. 24, 2137-2142
85. Chung, E. S., Packer, M., Lo, K. H., Fasanmade, A. A. and Willerson, J. T. (2003) Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation 107, 3133-3140
86. Feldman, A. and McTiernan, C. (2004) Is there any future for tumor necrosis factor antagonists in chronic heart failure? Am. J. Cardiovasc. Drugs 4, 11-19
87. Changelian, P. S., Flanagan, M. E., Ball, D. J. et al. (2003) Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor. Science 302, 875-878
88. Jackson, S. H., Yu, C. R., Mahdi, R. M., Ebong, S. and Egwuagu, C. E. (2004) Dendritic cell maturation requires STAT1 and is under feedback regulation by suppressors of cytokine signaling. J. Immunol. 172, 2307-2315
89. + stem cells from bone-marrow microenvironment. Nat. Med. 8, 841-849
90. Yamaguchi, J., Kusano, K. F., Masuo, O. et al. (2003) Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107, 1322-1328
91. Petit, I., Szyper-Kravitz, M., Nagler, A. et al. (2002) G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat. Immunol. 3, 687-694
92. Papayannopoulou, T., Priestley, G. V., Bonig, H. and Nakamoto, B. (2003) The role of G-protein signaling in hemopoietic stem/progenitor cell mobilization. Blood 101, 4739-4747
93. + cells induces marked and sustained changes in adhesion receptor and CXCR4 expressions. Stem Cells 21, 61-70